# PharmaOS — QA Phase 12: Final QA Certification

**Document ID:** QA-CERT-12
**Product:** PharmaOS Pharmacy Management SaaS
**Version certified:** V1.2.2 + post-QA fixes (malformed-JSON, dashboard single-flight)
**Certifying body:** Independent Enterprise QA
**Date:** 2026-07-15

---

## 1. Certification verdict

> ### ✅ CONDITIONALLY CERTIFIED FOR CONTROLLED PILOT
>
> PharmaOS passes functional, integration, workflow, API-contract, security (OWASP), performance, and regression testing with **0 open Critical or High defects**. It is certified for a **controlled pilot with real pharmacies**, subject to the deployment prerequisites (§5) being met and the Low-severity follow-ups (§6) tracked for GA.

The QA effort found and remediated one **Critical** authorization vulnerability that would have blocked any safe launch — the single most important outcome of this exercise.

---

## 2. Testing scorecard

| Phase | Area | Executed | Pass | Fail (open) |
|-------|------|----------|------|-------------|
| 3 | Authentication & Authorization | 33 | 33 | 0 |
| 4 | Module functional (13 modules) | 101 | 101 | 0 |
| 5 | Cross-module integration | 10 | 10 | 0 |
| 6 | End-to-end workflows | 5 | 5 | 0 |
| 7 | API contract | 10 | 10 | 0 |
| 8 | Security (OWASP Top-10) | 14 | 14 | 0 |
| 10 | Performance & reliability | targets met | ✅ | 0 |
| 11 | Regression + smoke | 173 + 8 | all | 0 |
| **Total executed** | | **~200 live cases** | **100%** | **0** |

Phases 1 (Strategy), 2 (240-scenario catalog), and 9 (UI/UX heuristic + WCAG review) delivered as documentation artifacts.

---

## 3. Defects found & disposition

| ID | Severity | Description | Status |
|----|----------|-------------|--------|
| DEF-001 | **Critical** | Authorization not enforced on any endpoint (privilege escalation + cross-tenant compromise) | ✅ Fixed & re-verified (V1.2.2) |
| DEF-002 | Medium | Auth rate limiter counted successful logins → shared-IP lockout | ✅ Fixed & re-verified |
| DEF-004 | Medium | Malformed JSON body returned 500 instead of 400 | ✅ Fixed & re-verified |
| DEF-005 | Low | Generic API error strings surface to users (item-shape validation) | Open (non-blocking) |
| PERF | Low | Dashboard cold-cache stampede | ✅ Mitigated (single-flight) |
| A11Y-1..3 | Low | Icon-label / focus-ring / axe-sweep follow-ups | Open (GA, non-blocking) |
| PUR-robustness | Low | Purchase/prescription/return item validation returns generic 400 | Open (non-blocking) |

**0 Critical open · 0 High open · 4 Low open (all non-blocking, tracked for GA).**

---

## 4. Requirements coverage (traceability)

Every in-scope requirement area from the Product Bible maps to ≥1 executed test:

✅ Auth/RBAC (§9) · ✅ Multi-tenant isolation (§9) · ✅ Billing + GST (§7,§10) · ✅ Schedule H/H1/X compliance · ✅ GSTR-1 · ✅ Inventory/batches/movements (§7) · ✅ Medicine master (§7) · ✅ Customers/Vendors/Purchase (§7) · ✅ Prescriptions/Returns (§7) · ✅ Reports (§7) · ✅ Notifications/Audit/Settings (§7) · ✅ Import/Export/Backup (V1.2) · ✅ Error handling (§11).

Deferred (documented, out of scope): Offline sync, OCR, GSTR-3B, real gateway delivery.

---

## 5. Deployment prerequisites (must be satisfied before pilot go-live)

These are **operational/account** items, not code — the software is wired for all of them via env vars:

1. **Rotate JWT secrets** — generate fresh `JWT_SECRET`/`JWT_REFRESH_SECRET` (`openssl rand -base64 48`); never ship the dev defaults.
2. **TLS** — provide `fullchain.pem`/`privkey.pem` for nginx (HTTPS mandatory for patient data).
3. **SMTP credentials** — for real OTP/alert email (else console fallback only).
4. **SMS/WhatsApp key** (MSG91/Twilio) — for refill/alert delivery (optional for pilot).
5. **Domain + VPS** — `docker compose up -d --build` per DEPLOYMENT.md.
6. **Fresh production DB** — run `prisma migrate deploy` + `db:seed`; do not carry the dev DB's QA test residue.

---

## 6. Recommendations for GA (post-pilot)

- Close the 4 Low-severity items (friendly error messages, item-level 422 validation, a11y follow-ups, dashboard warmup ping).
- Add an automated a11y (axe/Lighthouse) and the QA harnesses (Phases 3–8) to CI as a regression gate.
- Add per-role permission review UI so pharmacy admins can see exactly what each role can do.
- Consider a dedicated platform-admin role for multi-tenant onboarding (currently gated behind `settings:edit`).

---

## 7. Sign-off

| Role | Decision | Date |
|------|----------|------|
| Independent QA Lead | **Certified for controlled pilot** — 0 Critical/High open | 2026-07-15 |
| Product Owner | _pending_ | |

### Bottom line
The product that was described as "market-ready" two iterations ago had a **critical, unenforced access-control model** that this QA caught and fixed. With that closed and ~200 live tests passing across every module and security category, PharmaOS is now genuinely ready for a **supervised pilot with real pharmacies** once the deployment prerequisites are in place. A broad paid GA should follow a successful pilot and closure of the Low-severity GA list.

**Phase 12 status: COMPLETE. QA program complete.**
